Samsung Medison has announced plans to acquire Sonio, a French company specializing in fetal ultrasound AI software.

Sonio, established in 2020, focuses on improving global health for women and children by advancing obstetrics and gynecology ultrasound technology. Its products, including the FDA-cleared Sonio Detect, which utilizes deep learning to enhance image quality and clinical accuracy in real time during ultrasound examinations.

The purchase price came to about 126 billion won ($92.4 million), according to Reuters.

In an effort to preserve Sonio's innovative capabilities and ensure its products remain compatible with various ultrasound device manufacturers, it will operate as an independent entity within the Samsung Medison umbrella and maintain its headquarters in France.

“We have great respect and admiration for what the Sonio team has built in the area of maternal care. Through the acquisition of Sonio, Samsung Medison will continue to deliver upon our promise to improve the quality of people’s lives with technology,” said Yong Kwan Kim, Samsung Medison CEO. “Collaboration with Sonio will bring together best-in-class ultrasound AI technology and reporting capabilities to bring a paradigm shift in the prenatal ultrasound exam.”

The transaction's finalization is contingent on receiving necessary regulatory approvals, including from the French Ministry of the Economy and Finance.

Business Affairs Homepage